Header Logo
Last Name

Michelle Dianne Liedtke

InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmacy Clinical & Admin Sci
Address1110 N Stonewall Ave
Oklahoma City OK 73117-1200
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Durham SH, Badowski ME, Liedtke MD, Rathbun RC, Pecora Fulco P. Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2017 May; 37(5):611-629. PMID: 28273373.
      View in: PubMed
    2. Masich A, Badowski ME, Liedtke MD, Fulco PP. Evaluation of the concurrent use of dolutegravir and metformin in human immunodeficiency virus-infected patients. Int J STD AIDS. 2017 Oct; 28(12):1229-1233. PMID: 28632474.
      View in: PubMed
    3. Miller MM, Liedtke MD, Lockhart SM, Rathbun RC. The role of dolutegravir in the management of HIV infection. Infect Drug Resist. 2015; 8:19-29. PMID: 25733917; PMCID: PMC4340460.
    4. Liedtke MD, Tomlin CR, Lockhart SM, Miller MM, Rathbun RC. Long-term efficacy and safety of raltegravir in the management of HIV infection. Infect Drug Resist. 2014; 7:73-84. PMID: 24672249; PMCID: PMC3965364.
    5. Kleyn TJ, Liedtke MD, Harrison DL, Lockhart SM, Salvaggio MR, Ripley TL, Rathbun RC. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic. Ann Pharmacother. 2014 Apr; 48(4):470-5. PMID: 24473489.
      View in: PubMed
    6. Rathbun RC, Lockhart SM, Miller MM, Liedtke MD. Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection. Ann Pharmacother. 2014 Mar; 48(3):395-403. PMID: 24259658.
      View in: PubMed
    7. Liedtke MD, Vanguri A, Rathbun RC. A probable interaction between warfarin and the antiretroviral TRIO study regimen. Ann Pharmacother. 2012 Nov; 46(11):e34. PMID: 23115227.
      View in: PubMed
    8. Rathbun RC, Liedtke MD. Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management. Pharmaceutics. 2011 Oct 21; 3(4):745-81. PMID: 24309307; PMCID: PMC3857057.
    9. Liedtke MD, Rathbun RC. Drug interactions with antiretrovirals and warfarin. Expert Opin Drug Saf. 2010 Mar; 9(2):215-23. PMID: 20095918.
      View in: PubMed
    10. Rathbun CR, Liedtke MD, Blevins SM, Harrison D, Lockhart SM, Salvaggio M, Acosta EP. Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir. HIV Clin Trials. 2009 Sep-Oct; 10(5):328-36. PMID: 19906626.
      View in: PubMed
    11. Liedtke MD, Rathbun RC. Warfarin-antiretroviral interactions. Ann Pharmacother. 2009 Feb; 43(2):322-8. PMID: 19196837.
      View in: PubMed
    12. Liedtke MD, Lockhart SM, Rathbun RC. Anticonvulsant and antiretroviral interactions. Ann Pharmacother. 2004 Mar; 38(3):482-9. PMID: 14970370.
      View in: PubMed
    Liedtke's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description